Immediate Impact
1 from Science/Nature 64 standout
Citing Papers
Strategies to reduce the risks of mRNA drug and vaccine toxicity
2024 Standout
Cardiac Amyloidosis Due to Transthyretin Protein
2024 Standout
Works of Jonas Wixner being referenced
Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen
2022
THAOS: Gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jonas Wixner | 424 | 79 | 92 | 127 | 36 | 476 | |
| Keita Mori | 218 | 44 | 65 | 138 | 31 | 573 | |
| Hans Nienhuis | 285 | 44 | 39 | 100 | 36 | 493 | |
| Giorgia Panichella | 279 | 38 | 53 | 81 | 54 | 520 | |
| P Ranløv | 223 | 74 | 85 | 34 | 23 | 446 | |
| Samantha Milanesi | 206 | 35 | 104 | 118 | 29 | 506 | |
| P Verroust | 216 | 25 | 41 | 108 | 26 | 457 | |
| Nishio Honda | 162 | 31 | 73 | 158 | 37 | 525 | |
| Ewa Popowska | 340 | 56 | 77 | 39 | 36 | 548 | |
| Shinzaburo Hattori | 231 | 20 | 80 | 127 | 29 | 551 | |
| Roberta Mussinelli | 397 | 56 | 22 | 161 | 22 | 465 |
All Works
Login with ORCID to disown or claim papers
Loading papers...